AQST
Aquestive Therapeutics, Inc.
-0.04 (-0.93%)4.78USD647K成交股數599M市值–本益比(近四季)11.1股價營收比+38.1%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 13.8M+58% | 14.4M+22% | 12.8M-5% | 10.0M-50% | 8.7M-28% | 11.9M-9% | 13.5M+2% | 20.1M+81% | 12.1M | 13.0M | 13.2M | 11.1M |
| 營業成本 | 4.0M | 3.5M | 4.5M | 4.6M | 3.7M | 4.5M | 4.4M | 4.5M | 4.4M | 4.8M | 6.6M | 4.7M |
| 毛利 | 9.8M+93% | 11.0M+49% | 8.3M-9% | 5.4M-65% | 5.1M-34% | 7.3M-10% | 9.1M+37% | 15.6M+143% | 7.7M | 8.2M | 6.6M | 6.4M |
| 毛利率 | 70.9% | 76.0% | 64.8% | 54.4% | 58.1% | 61.9% | 67.2% | 77.5% | 63.6% | 63.1% | 50.0% | 57.5% |
| 研發費用 | 4.0M | 4.2M | 4.5M | 4.1M | 5.4M | 4.9M | 5.3M | 4.2M | 5.9M | 3.2M | 3.5M | 3.5M |
| 銷售管理費用 | 14.1M | 11.0M | 15.3M | 12.7M | 19.1M | 16.0M | 12.1M | 11.4M | 10.7M | 7.4M | 7.4M | 7.5M |
| 營業利益 | −8.2M-58% | −4.2M-69% | −11.5M+38% | −11.4M-20769% | −19.4M+116% | −13.6M+471% | −8.3M+97% | 55K-101% | −9.0M | −2.4M | −4.2M | −4.6M |
| 營業利益率 | -59.5% | -29.1% | -89.6% | -113.6% | -222.1% | -114.4% | -61.2% | 0.3% | -74.3% | -18.3% | -31.8% | -41.4% |
| 稅後淨利 | −22.9M-0% | −8.1M-53% | −15.4M+34% | −13.5M+394% | −22.9M+79% | −17.1M+738% | −11.5M+99% | −2.7M-134% | −12.8M | −2.0M | −5.8M | 8.1M |
| 淨利率 | -165.5% | -55.8% | -120.6% | -135.4% | -263.0% | -143.7% | -85.0% | -13.7% | -106.4% | -15.7% | -43.7% | 72.5% |
| 稀釋 EPS | -0.18-25% | -0.07-61% | -0.14+8% | -0.14+367% | -0.24+41% | -0.18+500% | -0.13+30% | -0.03-127% | -0.17 | -0.03 | -0.10 | 0.11 |
| 稀釋股數 | 125M | 123M | 111M | 99.3M | 95.5M | 86.7M | 91.1M | 90.9M | 73.6M | 64.7M | 57.4M | 73.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 98.5M | 111M | 129M | 60.5M | 68.7M | 71.5M | 77.9M | 89.9M | 95.2M | 24.9M | 22.4M | 26.9M |
| 應收帳款 | 9.3M | 6.9M | – | – | – | 7.3M | – | – | – | – | – | – |
| 存貨 | 7.4M | 8.1M | 7.9M | 8.1M | 7.2M | 6.0M | 7.0M | 7.0M | 7.7M | 7.1M | 6.0M | 7.0M |
| 總資產 | 132M | 141M | 164M | 93.7M | 102M | 101M | 110M | 118M | 130M | 59.4M | 57.0M | 61.3M |
| 有息負債 | 55.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 39.0M | 39.0M | 42.4M |
| 總負債 | 189M | 175M | 168M | 166M | 163M | 162M | 155M | 153M | 166M | 162M | 164M | 171M |
| 股東權益 | −56.6M | −34.1M | −4.1M | −72.6M | −60.9M | −60.2M | −45.4M | −35.5M | −36.3M | −103M | −107M | −109M |
| 負債比 | 142.8% | 124.1% | 102.5% | 177.5% | 159.6% | 159.3% | 141.3% | 130.2% | 128.0% | 273.1% | 287.1% | 278.2% |
| 淨現金(現金 − 有息負債) | 43.5M | 65.7M | 84.1M | 15.5M | 23.7M | 26.5M | 32.9M | 44.9M | 50.2M | −14.1M | −16.5M | −15.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −14.8M | – | – | −23.4M+125% | – | – | – | −10.4M | – | – | 8.8M |
| 資本支出 | – | 52K | – | – | 135K | – | – | – | 29K | – | – | 2K |
| 自由現金流 | – | −14.9M | – | – | −23.5M+126% | – | – | – | −10.4M | – | – | 8.8M |
| 折舊攤銷 | – | 113K | – | – | 139K | – | – | – | 207K | – | – | 325K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -102.9% | – | – | -269.9% | – | – | – | -86.4% | – | – | 79.2% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 44.5M
| Reportable | 44.5M | 100.0% | -22.6% |
|---|
地區2025 年度 · 44.5M
| 美國 | 29.6M | 66.5% | -25.9% |
|---|---|---|---|
| 美國以外 | 14.9M | 33.5% | -15.3% |
產品／服務2025 年度 · 46.0M
| Manufacture And Supply Revenue | 40.2M | 87.5% | +0.6% |
|---|---|---|---|
| License And Royalty Revenue | 3.5M | 7.7% | -77.1% |
| Co Development And Research Fees | 1.3M | 2.8% | -33.6% |
| Royalty | 938K | 2.0% | -6.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 44.5M | -22.6% | −83.8M | -188.1% | -0.78 | −53.0M |
| FY2024 | 57.6M | +13.8% | −44.1M | -76.7% | -0.51 | −35.9M |
| FY2023 | 50.6M | +6.1% | −7.9M | -15.6% | -0.13 | −7.4M |
| FY2022 | 47.7M | -6.2% | −54.4M | -114.1% | -1.12 | −10.8M |
| FY2021 | 50.8M | +10.9% | −70.5M | -138.8% | -1.85 | −33.9M |
| FY2020 | 45.8M | -12.8% | −55.8M | -121.7% | -1.66 | −46.0M |
| FY2019 | 52.6M | -22.0% | −66.2M | -125.9% | -2.61 | −60.9M |
| FY2018 | 67.4M | – | −61.4M | -91.0% | -2.96 | −14.8M |